HLI stockholder files Rule 144 notice to sell 500 shares

An HLI stockholder has filed a notice under Rule 144 to sell 500 shares of common stock.

Rhea-AI Filing Summary

An HLI stockholder has filed a notice under Rule 144 to sell 500 shares of common stock. The shares are to be sold through Morgan Stanley Smith Barney LLC on the NYSE, with an indicated aggregate market value of $87,095.00. The filing notes that 54,515,003 shares of this class of common stock were outstanding at the time of the notice.

The 500 shares were acquired on 05/15/2024 directly from the issuer in an RSA (restricted stock award) transaction, with no separate cash payment described. The Rule 144 notice also repeats the standard representation that the selling holder does not know of any undisclosed material adverse information about the issuer.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does the HLI Rule 144 filing disclose about planned share sales?

The filing discloses that a stockholder plans to sell 500 shares of HLI common stock under Rule 144, using Morgan Stanley Smith Barney LLC as broker on the NYSE, with an aggregate market value of $87,095.00.

How many HLI shares are outstanding according to this Rule 144 notice?

The notice states that there were 54,515,003 shares of the relevant class of HLI common stock outstanding at the time of the filing.

When and how were the 500 HLI shares being sold under Rule 144 acquired?

The 500 HLI common shares were acquired on 05/15/2024 from the issuer through an RSA (restricted stock award), with the nature of payment shown as N/A.

What is the approximate planned sale date for the HLI shares in this filing?

The filing lists an approximate date of sale of 01/02/2026 for the 500 HLI common shares to be sold on the NYSE.

Which broker is handling the HLI Rule 144 stock sale?

The planned sale of 500 HLI common shares under Rule 144 is to be executed through Morgan Stanley Smith Barney LLC Executive Financial Services, based at 1 New York Plaza, 8th Floor, New York, NY 10004.

What representation does the selling HLI stockholder make in this Rule 144 notice?

The selling stockholder represents that they do not know any material adverse information about the issuer’s current or prospective operations that has not been publicly disclosed, as required by the form.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 01/02/2026 - 04:32 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001649160
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	Houlihan Lokey, Inc.
SEC File Number	001-37537
Address of Issuer	10250 Constellation Blvd, 5th Floor Los Angeles CALIFORNIA 90067
Phone	3105538871
Name of Person for Whose Account the Securities are To Be Sold	CHRISTOPHER MADISON CRAIN
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	500	87095.00	54515003	01/02/2026	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	05/15/2024	RSA	Issuer			500	05/15/2024	N/A

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks
Date of Notice	01/02/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	11/18/2024
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Christopher Crain
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)